Evolution of ”The Guideline Advantage”: Lessons Learned From the Front Lines of Outpatient Performance Measurement
Heart disease, cancer, stroke, and diabetes mellitus collectively account for >1.37 million US deaths each year. Compounding the tragedy is the knowledge that many of those deaths could be avoided through better application of clinical guidelines related to primary and secondary prevention or dis- ease management. The combined control of blood pressure, lipids, and glucose has been shown to substantially reduce mortality and cardiovascular events.2,3 Screening for colon, cervical, breast, and lung cancer has been proven to reduce age-adjusted mortality from these diseases.4 In recognition of the common risk factors across these disease areas, the chief executive officers of the American Cancer Society, American Diabetes Association, and American Heart Association formed the Preventive Health Partnership in 2004. The 3 organizations have been working closely ever since to increase public awareness about healthy lifestyles, support policies that increase funding for and access to prevention programs and research, and increase the focus on prevention among health- care providers.
The American Cancer Society, American Diabetes Asso- ciation, and American Heart Association have long developed scientific statements and evidence-based guidelines that pro- mote public health services and clinical interventions of known efficacy for improving patient outcomes. Thus, maximizing adherence to quality-of-care guidelines is a high priority for each organization, because this will save lives and improve quality of life. This common purpose has served as a focal point for much of the collaborative work undertaken by the 3 organizations, including The Guideline Advantage (TGA). Read More